Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists
B. Evans, Kenneth E. Rittle, Mark G. Bock et al. · Journal of Medicinal Chemistry · 1988
3-(Acylamino)-5-phenyl-2H-1,4-benzodiazepines, antagonists of the peptide hormone cholecystokinin (CCK), are described. Developed by reasoned modification of the known anxiolytic benzodiazepines, these compounds provide highly potent, orally effective ligands selective for peripheral (CCK-A) receptors, with binding affinities approaching or equaling that of the natural ligand CCK-8. The distinction between CCK-A receptors on the one hand and CNS (CCK-B), gastrin, and central benzodiazepine receptors on the other is demonstrated by using the structure-activity profiles of the new compounds. Details of the binding of these agents to CCK-A receptors are examined, and the method of development of these compounds is discussed in terms of its relevance to the general problem of drug discovery.
Cited by 1,456 works. doi:10.1021/jm00120a002
Authors
- B. Evans
- Kenneth E. Rittle
- Mark G. Bock
- Robert M. DiPardo
- Roger M. Freidinger
- Willie L. Whitter
- George F. Lundell
- Daniel F. Veber
- Paul Anderson
- Raymond S.L. Chang
- Victor J. Lotti
- Deborah J. Cerino
- T B Chen
- Paul J. Kling
- K. A. Kunkel
- James Patrick Springer
- J. HIRSHFIELD
References
- Method for Determination of the Amino Acid Sequence in Peptides.
- Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors.
- Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.
- A Rearrangement of 5-Aryl-1,3-dihydro-2H-1,4-benzodiazepine-2-one 4-Oxides1
- Solid‐Phase Methods in Protein Sequence Analysis
- Quinazolines and 1,4-Benzodiazepines. VI.1a Halo-, Methyl-, and Methoxy-substituted 1,3-Dihydro-5-phenyl-2H-1,4-benzodiazepin-2-ones1b,c
- An opioid benzodiazepine
- The Schild regression in the process of receptor classification
- Synthesis of cholecystokinin-pancreozymin. I. C-terminal dodecapeptide
- Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones